Profile | GDS4284 / 226817_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 289.145 | 56 |
GSM687648 | Patient 402 control | 975.589 | 74 |
GSM687653 | Patient 403 control | 460.62 | 63 |
GSM687658 | Patient 404 control | 1506.09 | 80 |
GSM687663 | Patient 411 control | 1025.21 | 74 |
GSM687668 | Patient 422 control | 429.623 | 61 |
GSM687673 | Patient 424 control | 550.735 | 64 |
GSM687678 | Patient 425 control | 826.93 | 70 |
GSM687683 | Patient 427 control | 644.617 | 66 |
GSM687688 | Patient 428 control | 168.371 | 45 |
GSM687695 | Patient 441 control | 3861.31 | 92 |
GSM687699 | Patient 443 control | 1056.92 | 75 |
GSM687704 | Patient 444 control | 334.895 | 57 |
GSM687707 | Patient 448 control | 724.723 | 69 |
GSM687712 | Patient 449 control | 299.26 | 55 |
GSM687719 | Patient 450 control | 1597.43 | 81 |
GSM687724 | Patient 451 control | 676.91 | 68 |
GSM687728 | Patient 452 control | 2419.12 | 86 |
GSM687646 | Patient 401 treated 24h | 233.651 | 51 |
GSM687649 | Patient 402 treated 24h | 789.324 | 70 |
GSM687665 | Patient 411 treated 24h | 1175.48 | 76 |
GSM687651 | Patient 402 treated 4 weeks | 842.875 | 71 |
GSM687667 | Patient 411 treated 4 weeks | 773.228 | 70 |
GSM687670 | Patient 422 treated 24h | 469.821 | 62 |
GSM687671 | Patient 422 treated 4 weeks | 413.4 | 61 |
GSM687654 | Patient 403 treated 24h | 581.636 | 66 |
GSM687675 | Patient 424 treated 24h | 572.198 | 65 |
GSM687685 | Patient 427 treated 24h | 572.381 | 65 |
GSM687656 | Patient 403 treated 4 weeks | 352.463 | 59 |
GSM687677 | Patient 424 treated 4 weeks | 354.141 | 58 |
GSM687687 | Patient 427 treated 4 weeks | 494.652 | 63 |
GSM687692 | Patient 428 treated 4h | 544.496 | 65 |
GSM687716 | Patient 449 treated 4h | 198.548 | 49 |
GSM687722 | Patient 450 treated 4h | 1363.25 | 79 |
GSM687680 | Patient 425 treated 24h | 601.432 | 66 |
GSM687690 | Patient 428 treated 24h | 518.178 | 65 |
GSM687700 | Patient 443 treated 24h | 2541.44 | 87 |
GSM687705 | Patient 444 treated 24h | 712.801 | 69 |
GSM687714 | Patient 449 treated 24h | 393.299 | 61 |
GSM687721 | Patient 450 treated 24h | 1864.49 | 83 |
GSM687682 | Patient 425 treated 4 weeks | 684.02 | 69 |
GSM687694 | Patient 428 treated 4 weeks | 317.137 | 57 |
GSM687702 | Patient 443 treated 4 weeks | 847.116 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 218.411 | 50 |
GSM687723 | Patient 450 treated 4 weeks | 1029.08 | 74 |
GSM687661 | Patient 404 treated 4h | 1295.07 | 78 |
GSM687710 | Patient 448 treated 4h | 696.117 | 69 |
GSM687726 | Patient 451 treated 4h | 533.169 | 64 |
GSM687730 | Patient 452 treated 4h | 1795.61 | 84 |
GSM687660 | Patient 404 treated 24h | 16747.3 | 98 |
GSM687697 | Patient 441 treated 24h | 4011.92 | 92 |
GSM687709 | Patient 448 treated 24h | 750.085 | 70 |
GSM687725 | Patient 451 treated 24h | 712.44 | 69 |
GSM687729 | Patient 452 treated 24h | 7643.5 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 887.465 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 1417.79 | 79 |